- Home
- IMRN
IMRN
Immuron Limited
as 12-18-2024 1:38pm EST
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
| Founded: | 1994 | Country: | Australia |
| Employees: | N/A | City: | N/A |
| Market Cap: | 15.0M | IPO Year: | N/A |
| Target Price: | $5.00 | AVG Volume (30 days): | 6.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.59 - $5.96 | Next Earning Date: | 12-31-2024 |
| Revenue: | $3,271,194 | Revenue Growth: | 171.67% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Immuron Limited News
IMRN Breaking Stock News: Dive into IMRN Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
GlobeNewswire
12 days ago
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
ACCESSWIRE
15 days ago
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
GlobeNewswire
15 days ago
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
GlobeNewswire
16 days ago
Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th
GlobeNewswire
a month ago
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
ACCESSWIRE
a month ago
Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event
GlobeNewswire
2 months ago
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
Compare IMRN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IMRN Immuron Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.